Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 144 results for "Suboxone Tablets"

Methadone alternative to be made available to drug addicts
Irish Times

Methadone alternative to be made available to drug addicts

Introduction of Suboxone delayed because of need for specific legislation An alternative to methadone for treating people with heroin and other opiate drug addictions is to be made widely available after the Department of Health agreed to provide ... Irish Times, 3 weeks ago

2 images for "Suboxone Tablets"

CNN Money, 3 weeks ago
Irish Examiner, 5 months ago

BUCCAL DRUG DELIVERY SYSTEMS: OPPORTUNITIES AND CHALLENGES IN BUCCAL, SUBLINGUAL FILMS, TABLETS & SPRAYS - Detailed analysis on Technologies and Pipeline Development

Within the oral mucosal cavity, the buccal region offers an attractive route of administration for systemic drug delivery. The mucosa has a rich blood supply and it is relatively permeable. The buccal mucosa offers several advantages for controlled ...
 International Business Times1 month ago

OREXO : signs license agreement with Mundipharma, which obtains ex-US global rights to Zubsolv®

- Orexo AB (publ.) today announced an agreement granting Mundipharma's network of independent associated companies' exclusive global (ex-US) rights to Zubsolv® (buprenorphine and naloxone) sublingual tablet (CIII), for treatment of opioid ...
 4 Traders4 hours ago Orexo signs license agreement with Mundipharma, which obtains ex-US global rights to Zubsolv  FirstWord Pharma54 minutes ago
[x]  

INDIVIOR PLC SPON ADR EA REPR 5 (INVVY) Downgraded to Strong Sell at Zacks Investment Research

INDIVIOR PLC SPON ADR EA REPR 5 (NASDAQ:INVVY) was downgraded by Zacks Investment Research from a hold rating to a strong sell rating in a research report issued on Wednesday. According to Zacks, Indivior PLC operates as a specialty pharmaceutical ...
 American Banking News7 hours ago Zacks Investment Research Lowers INDIVIOR PLC SPON ADR EA REPR 5 (INVVY) to Sell  American Banking News - Stock Ratings2 months ago
[x]  

Analysts Downgrades for June, 29th (DRII, FCFS, FIX, FLEX, GEO, GNRT, GRC, GWB, GWGH, IHG)

Analysts downgrades for Wednesday, June 29th: Diamond Resorts International (NASDAQ:DRII) was downgraded by analysts at Goldman Sachs from a buy rating to a neutral rating. First Cash Financial Services (NASDAQ:FCFS) was downgraded by analysts at ...
 American Banking News - Earnings7 hours ago

Gun control? Try pill control first

There's a cycle in this country that goes like this: Shooting, call for gun control, Democratic rail against Republican refusal to pass senseless gun control, and brief lull and calm before the next shooting and gun control storm. The latest in ...
 WorldNetDaily12 hours ago

Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights Hearing

Testimony by Robin Feldman , Harry & Lillian Hastings Professor Of Law, Director Of The Institute For Innovation Law, UC Hastings College Of Law, San Francisco, CA Mr. Chairman and esteemed members of the Committee, it is an honor to testify ...
 Insurance News Net1 week ago
BioSpace

Seventeen Days after Receiving FDA Approval, Braeburn Pharmaceuticals Announces First Patients Have Received Probuphine® (buprenorphine) Implant

PRINCETON, N.J. , June 20, 2016 /PRNewswire/ -- Braeburn Pharmaceuticals announces that 10 patients have already been treated with the Probuphine (buprenorphine) Implant, making them the first people in the United States to receive this new ...
 Minyanville1 week ago Titan Pharmaceuticals Announces FDA Approval of Probuphine(R) for the Treatment of Opioid Dependence  Nasdaq1 month ago First Implant to Treat Opioid Addiction Gets FDA Approval  Bloomberg1 month ago Braeburn Pharma Announces FDA Approves Probuphine (Buprenorphine) Implant: The First Implant For Treatment Of Opioid Dependence  BioSpace1 month ago
[x]  

Probuphine® (buprenorphine) Implant Phase 3 Data Presented at CPDD Annual Scientific Meeting

/PRNewswire/ -- Braeburn Pharmaceuticals presented data yesterday from the poster of the Phase 3 study of Probuphine, a six-month subdermal buprenorphine implant for the long-term maintenance treatment of opioid dependence, at the 78(th) Annual ...
 4 Traders1 week ago Braeburn Pharma Release: Probuphine (buprenorphine) Implant Phase 3 Data Presented At Annual Scientific Meeting  BioSpace1 week ago Probuphine ® (buprenorphine) Implant Phase 3 Data Presented at CPDD Annual Scientific Meeting  Stockwatch1 week ago
[x]  

Fentanyl: the Scariest Opioid?

With 50 times the strength of heroin, fentanyl poses a rising threat. Last week, an autopsy revealed that superstar musician Prince died from a fentanyl overdose. The tragedy has drawn attention to a powerful drug that until recently flew under the ...
 US News & World Report2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less